Immunic Appoints Jaa Roberson as Chief People Officer

Erik Lundgren, Chief Executive Officer of Immunic

“Over the past several months, we have been assembling a leadership team with deep experience in MS and a track record of successfully developing and commercializing important therapies for patients.”

Erik Lundgren, Chief Executive Officer of Immunic

“Our continued goal is to build an exceptional MS organization with the right people and capabilities in place.”

Erik Lundgren, Chief Executive Officer of Immunic

“I am thrilled that Jaa joins us at this critical time, with the pivotal Phase 3 data in relapsing MS expected by year-end and our progressive MS trial preparations advancing.”

Erik Lundgren, Chief Executive Officer of Immunic

“Jaa will be a strategic partner on the management team helping us attract, develop, and retain world-class talent while building the structures, systems, and culture necessary for scaling from a research and development biotechnology company toward a fully integrated commercial organization.”

Jaa Roberson, Chief People Officer of Immunic

“I am excited to join Immunic at such an important stage in the company’s evolution.”

Jaa Roberson, Chief People Officer of Immunic

“Immunic has assembled a strong leadership team with deep experience across MS research and development, regulatory and commercialization.”

Jaa Roberson, Chief People Officer of Immunic

“With the pivotal Phase 3 data approaching, my focus will be on building the broader organization and continuing to attract the specialized talent, capabilities, and culture needed to support potential regulatory approval and commercialization, while preserving the agility and focus that differentiate Immunic as a biotechnology company.”